Stockreport

ImmunoGen Reports Recent Progress and First Quarter 2020 Financial Results

ImmunoGen, Inc.  (IMGN) 
Last immunogen, inc. earnings: 5/1 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.immunogen.com/investor-relations
PDF Pivotal SORAYA Trial Initiated for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian CancerData from FORWARD II Avastin® Expansion Cohort in Platinum-Agnostic Ovar [Read more]